China News Service, Xiamen, October 23 (Yang Fushan, Gao Shuzhuo) The awarding ceremony of the National Cardiovascular Disease Clinical Medical Research Center Branch was held on the 23rd at the Cardiovascular Hospital Affiliated to Xiamen University ("Xiaxin"). This is The only national sub-center in the field of cardiovascular diseases in Fujian Province, and the first approved national clinical medical research sub-center in Xiamen.
Liao Huasheng, deputy mayor of Xiamen, Li Jing, executive deputy director of the National Center for Cardiovascular Diseases Clinical Medicine, Ye Bihai, deputy director of Fujian Science and Technology Department, Wang Xiying, deputy director of Fujian Health Commission, and Quanhai, deputy secretary of the Party Committee of Xiamen University, attended the meeting. Licensing ceremony.
The awarding ceremony of the National Cardiovascular Disease Clinical Medicine Research Center Branch Center was held on the 23rd in the Cardiovascular Hospital Affiliated to Xiamen University.
Photo by Yang Fushan
Cardiovascular disease is the largest category of diseases that endanger the health of urban and rural residents in China. The National Center for Cardiovascular Diseases (Fuwai Hospital, Chinese Academy of Medical Sciences), as the National Center for Cardiovascular Disease Clinical Medicine Each province has a sub-center, and after a rigorous selection of evaluations, Xiaxin has become a sub-center of Fujian Province.
Li Jing said in her speech that Xiaxin has been actively participating in clinical research led by the National Center for Cardiovascular Diseases for a long time, and has completed various studies with high quality. It has excellent medical technology, medical environment, scientific research level and talent team building. score.
"I believe that in the near future, the hospital will yield fruitful results in clinical medical research and become a radiological and influential cardiovascular clinical medical research center in the Southeast."
As the only specialized cardiovascular hospital in Fujian Province, Xiaxin, established in 2001, has established an international heart-saving team and continues to grow.
The cardiology department of the hospital is the only national key clinical specialty of cardiovascular medicine in Fujian Province. The annual operation volume and complexity ranks first in the province. Cardiac Surgery is a provincial-level clinical key specialty. The operation volume has exceeded 1,000 for two consecutive years. The hospital has nearly 10 The number of minimally invasive interventional operations carried out in recent years is the largest in the province.
Li Jing, executive deputy director of the National Center for Cardiovascular Diseases Clinical Medicine, was interviewed by the media.
Photo by Yang Fushan
Statistics show that in the performance appraisal of national public hospitals in 2018 and 2019, Xiaxin’s CMI value (an indicator reflecting the degree of difficulty and complexity of the hospital’s diagnosis and treatment of diseases) ranked second in the country for other specialized surgery groups for two consecutive years, second only to Fuwai Hospital, Chinese Academy of Medical Sciences.
As one of the first domestic hospitals to carry out parachute technology for ventricular aneurysm, the amount and success rate of heart surgery are in the leading position in the world; it is the first in the Asia-Pacific region to carry out minimally invasive "folding" volume reduction surgery for ventricular aneurysm, which is the world's completion of this operation. The largest number of medical institutions; it has always been a domestic leader in the field of minimally invasive valves. It was the first to carry out simultaneous biovalvular replacement (VIV) in China, and recently completed the world's first domestic self-developed mitral valve edge-to-edge repair system. Implant.
In addition, the hospital also carried out the first minimally invasive mitral valve annuloplasty (AMEND system) in the Asia-Pacific region, and routinely carried out the "ultimate weapon for critical care"-ECMO life support technology, aortic dissection, heart transplantation and other high-precision techniques. Surgical operations have saved many endangered patients whose heartbeat and blood pressure have "stopped", and the traditional concept of recovery is lack of surgery.
Wang Yan, President of Xia Xin, said that the approval of the National Cardiovascular Disease Clinical Medical Research Center Branch is a full affirmation of the hospital's comprehensive strength. It will make full use of the national medical research platform to give full play to the advantages of specialists and further improve in all aspects. Clinical medical research and transformation capabilities can better benefit patients with cardiovascular diseases.
(over)